‘I Would Love To Have All The Biologic Assets’ – Formycon’s Glombitza Sets Out Portfolio Approach

Formycon CEO Talks Candidate Selection Strategy And Recent Biosimilar Regulatory Changes

 
• By David Wallace
  
Charts and graphs in blue
A number of factors play into Formycon’s portfolio selection strategy • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products